These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 2738720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prenatal and postnatal prophylaxis of infections in preterm neonates.
    von Muralt G, Sidiropoulos D.
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.
    Benjamin DK, Schelonka R, White R, Holley HP, Bifano E, Cummings J, Adcock K, Kaufman D, Puppala B, Riedel P, Hall B, White J, Cotton CM, S. aureus prevention investigators.
    J Perinatol; 2006 May; 26(5):290-5. PubMed ID: 16598296
    [Abstract] [Full Text] [Related]

  • 5. [Serum levels of IgG subclasses in critically ill premature infants treated with intravenous immunoglobulins].
    Puccio VF, Soliani M, Corea D, Puncuh F, Massone ML, Nahum L, Pisano F, Castellani R, Cornaglia-Ferraris P.
    Minerva Pediatr; 1991 Oct; 43(10):637-44. PubMed ID: 1758385
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin subclass concentration in preterm infants treated prophylactically with different intravenous immunoglobins.
    Amato M, Hüppi P, Imbach P, Llauto A, Bürgi W.
    Am J Perinatol; 1995 Sep; 12(5):306-9. PubMed ID: 8540928
    [Abstract] [Full Text] [Related]

  • 7. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
    Lassiter HA, Robinson TW, Brown MS, Hall DC, Hill HR, Christensen RD.
    J Perinatol; 1996 Sep; 16(5):346-51. PubMed ID: 8915932
    [Abstract] [Full Text] [Related]

  • 8. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL, Van Aerde JE, Gross S, Stolz SI, Harris CL, Hansen JW.
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [Abstract] [Full Text] [Related]

  • 14. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis.
    Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR.
    J Pediatr; 1991 Apr; 118(4 Pt 1):606-14. PubMed ID: 1901083
    [Abstract] [Full Text] [Related]

  • 15. The use of intravenous gamma-globulin for prevention of sepsis in pre-term infants. A controlled clinical trial.
    Didato MA, Gioeli R, Priolisi A.
    Helv Paediatr Acta; 1989 Feb; 43(4):283-94. PubMed ID: 2651367
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, Roman A, Stevens E, Vercammen E, Beaver JS.
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P, Messer J, Paupe A, Espagne S, Kacet N, Mouchnino G, Klosowski S, Krim G, Lescure S, Le Bouedec S, Meyer P, Astruc D.
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 19. Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis.
    Shenoi A, Nagesh NK, Maiya PP, Bhat SR, Subba Rao SD.
    Indian Pediatr; 1999 Nov; 36(11):1113-8. PubMed ID: 10745332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.